These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38953410)

  • 1. "Prompt" for PREEMPT: Dotting the I's and Crossing the T's With Ultrasound.
    Abdulsalam AJ; Analay P; Kara M; El Oumri AA; Özçakar L
    J Ultrasound Med; 2024 Jul; ():. PubMed ID: 38953410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing radionuclide protocols: Dotting our I's and crossing our T's.
    Aggarwal NR
    J Nucl Cardiol; 2019 Dec; 26(6):1875-1877. PubMed ID: 29766447
    [No Abstract]   [Full Text] [Related]  

  • 3. Crossing T's & dotting I's.
    Jeremiah M
    Caring; 2012 Dec; 31(12):64-5. PubMed ID: 23590071
    [No Abstract]   [Full Text] [Related]  

  • 4. Dotting the I's and crossing the T's: A South Australian perspective on variability in troponin thresholds for myocarditis risk in clozapine treatment.
    Clark SR; Wilton LR; Dawson JL; Chiew K; Jawahar MC; Toben C; Pukala T; Ajaero C; Saleem M
    Schizophr Res; 2024 Jun; 268():114-117. PubMed ID: 37516549
    [No Abstract]   [Full Text] [Related]  

  • 5. [Method of onabotulinumtoxin type A injection in chronic migraine: the PREEMPT protocol in clinical practice].
    Latysheva NV; Naprienko MV; Filatova EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):93-96. PubMed ID: 34481443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dotting the I's and crossing the T's: integration analyses in transduced patient T cells.
    Rossi JJ
    Mol Ther; 2009 May; 17(5):756-7. PubMed ID: 19404325
    [No Abstract]   [Full Text] [Related]  

  • 7. Injection technique of the upper face with onabotulinumtoxinA in chronic migraine.
    Boczarska-Jedynak M; Blumenfeld AM
    Headache; 2023; 63(7):849-860. PubMed ID: 37366143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice.
    Begasse de Dhaem O; Gharedaghi MH; Rizzoli P
    Headache; 2020 Jul; 60(7):1365-1375. PubMed ID: 32335918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological reporting of pT4 tumour stage in colorectal carcinomas: dotting the 'i's and crossing the 't's.
    Swamy R
    J Clin Pathol; 2010 Feb; 63(2):110-5. PubMed ID: 20154030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of two different botulinum toxin type A dilutions in chronic migraineurs.
    Tereshko Y; Lettieri C; Belgrado E; Pez S; Gigli GL; Valente M
    Toxicon; 2023 May; 227():107096. PubMed ID: 36965713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic migraine with intramuscular pericranial injections of onabotulinumtoxin a.
    Belvis R; Mas N
    Recent Pat CNS Drug Discov; 2014; 9(3):181-92. PubMed ID: 25643127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OnabotulinumtoxinA injection in the treatment of chronic migraine.
    Wang YF
    Prog Brain Res; 2020; 255():171-206. PubMed ID: 33008506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.
    Barbero P; Busso M; Tinivella M; Artusi CA; De Mercanti S; Cucci A; Veltri A; Avagnina P; Calvo A; Chio' A; Durelli L; Clerico M
    J Neurol; 2015 Dec; 262(12):2662-7. PubMed ID: 26410746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience.
    Vernieri F; Paolucci M; Altamura C; Pasqualetti P; Mastrangelo V; Pierangeli G; Cevoli S; D'Amico D; Grazzi L
    Headache; 2019 Sep; 59(8):1300-1309. PubMed ID: 31454075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic guide for botulinum toxin injections for chronic migraine headache: EURO-MUSCULUS/USPRM approach.
    Kara M; Ricci V; Pirri C; Sekizkardeş M; Cocco G; Stecco C; Kaymak B; Özçakar L
    Clin Neurol Neurosurg; 2023 Sep; 232():107883. PubMed ID: 37467578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic migraine with botulinum neurotoxin A : Expert recommendations of the German Migraine and Headache Society].
    Ruscheweyh R; Förderreuther S; Gaul C; Gendolla A; Holle-Lee D; Jürgens T; Neeb L; Straube A
    Nervenarzt; 2018 Dec; 89(12):1355-1364. PubMed ID: 29947936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic migraine long-term regular treatment with onabotulinumtoxinA: a retrospective real-life observational study up to 4 years of therapy.
    Santoro A; Copetti M; Miscio AM; Leone MA; Fontana A
    Neurol Sci; 2020 Jul; 41(7):1809-1820. PubMed ID: 32052306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Educating and Transitioning a Diverse Nursing Workforce: LPN to BSN.
    Huun KM; Kummerow A; Jenkins JT
    J Contin Educ Nurs; 2021 Dec; 52(12):558-564. PubMed ID: 34870528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technique of injection of onabotulinumtoxin A for chronic migraine: the PREEMPT injection paradigm.
    Liberini P; Pari E; Gazzina S; Caratozzolo S; Rao R; Padovani A
    Neurol Sci; 2014 May; 35 Suppl 1():41-3. PubMed ID: 24867834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
    Aurora SK; Dodick DW; Diener HC; DeGryse RE; Turkel CC; Lipton RB; Silberstein SD
    Acta Neurol Scand; 2014 Jan; 129(1):61-70. PubMed ID: 24107267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.